427 related articles for article (PubMed ID: 16912011)
1. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.
Khan N; Huang JJ; Foster CS
Semin Ophthalmol; 2006; 21(3):135-41. PubMed ID: 16912011
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.
Murphy MA; Thirkill CE; Hart WM
J Neuroophthalmol; 1997 Jun; 17(2):77-83. PubMed ID: 9176775
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
4. [Carcinoma-associated retinopathy: a review with clinical examples].
Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
[TBL] [Abstract][Full Text] [Related]
5. A clinical triad to diagnose paraneoplastic retinopathy.
Jacobson DM; Thirkill CE; Tipping SJ
Ann Neurol; 1990 Aug; 28(2):162-7. PubMed ID: 2171418
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma-associated retinopathy-an electrophysiological and immunohistochemical correlation.
Link B; Schlötzer-Schrehardt U; Jünemann A
Retina; 2009 Jan; 29(1):69-72. PubMed ID: 18728619
[TBL] [Abstract][Full Text] [Related]
7. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
8. Choroidal neovascularization associated with cancer-associated retinopathy.
Querques G; Thirkill CE; Hagege H; Soubrane G; Souied EH
Acta Ophthalmol; 2010 Aug; 88(5):571-5. PubMed ID: 19141145
[TBL] [Abstract][Full Text] [Related]
9. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
[TBL] [Abstract][Full Text] [Related]
10. Müller cell-specific autoantibodies in a patient with progressive loss of vision.
Peek R; Verbraak F; Coevoet HM; Kijlstra A
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1976-9. PubMed ID: 9727423
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to 46-kDa retinal antigen in a patient with breast carcinoma and cancer-associated retinopathy.
Ejma M; Misiuk-Hojło M; Gorczyca WA; Podemski R; Szymaniec S; Kuropatwa M; Rogozińska-Szczepka J; Bartnik W
Breast Cancer Res Treat; 2008 Jul; 110(2):269-71. PubMed ID: 17851760
[TBL] [Abstract][Full Text] [Related]
12. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells.
Thirkill CE; FitzGerald P; Sergott RC; Roth AM; Tyler NK; Keltner JL
N Engl J Med; 1989 Dec; 321(23):1589-94. PubMed ID: 2555714
[No Abstract] [Full Text] [Related]
14. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
[TBL] [Abstract][Full Text] [Related]
15. Cone dysfunction as a paraneoplastic syndrome associated with retinal antigens approximating 40 kiloDalton.
Parc CE; Azan E; Bonnel S; Sahel JA; Kaplan J; Thirkill CE
Ophthalmic Genet; 2006 Jun; 27(2):57-61. PubMed ID: 16754207
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings.
Jacobzone C; Cochard-Marianowski C; Kupfer I; Bettembourg S; Dordain Y; Misery L; Cochener B; Sassolas B
Arch Dermatol; 2004 Oct; 140(10):1258-61. PubMed ID: 15492190
[TBL] [Abstract][Full Text] [Related]
17. [Ocular manifestations of cancer].
De Potter P; Disneur D; Levecq L; Snyers B
J Fr Ophtalmol; 2002 Feb; 25(2):194-202. PubMed ID: 11941243
[TBL] [Abstract][Full Text] [Related]
18. Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology.
Mantel I; Ramchand KV; Holder GE; Ohbayashi M; Morohoshi K; Patel N; Toda M; Fitzke FW; Bird AC; Ono SJ
Exp Mol Pathol; 2008 Apr; 84(2):90-101. PubMed ID: 18255057
[TBL] [Abstract][Full Text] [Related]
19. Waldenström's macroglobulinemia-associated retinopathy.
Sen HN; Chan CC; Caruso RC; Fariss RN; Nussenblatt RB; Buggage RR
Ophthalmology; 2004 Mar; 111(3):535-9. PubMed ID: 15019332
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic pemphigus: a brief update.
Wade MS; Black MM
Australas J Dermatol; 2005 Feb; 46(1):1-8; quiz 9-10. PubMed ID: 15670168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]